Literature DB >> 22030546

Stroke research at a crossroad: asking the brain for directions.

Costantino Iadecola1, Josef Anrather.   

Abstract

Ischemic stroke remains a vexing public health problem. Although progress has been made in prevention and supportive care, efforts to protect the brain from ischemic cell death have failed. Thus, no new treatment has made it from bench to bedside since tissue plasminogen activator was introduced in 1996. The brain has a remarkable capacity for self-preservation, illustrated by the protective responses induced by ischemia, preconditioning and exercise. Here we describe the mechanisms underlying brain self-protection, with the goal of identifying features that could provide insight into stroke therapy. Unlike traditional therapeutic approaches based on counteracting selected pathways of the ischemic cascade, endogenous neuroprotection relies on coordinated neurovascular programs that support cerebral perfusion, mitigate the harmful effects of cerebral ischemia and promote tissue restoration. Learning how the brain triggers and implements these protective measures may advance our quest to treat stroke.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22030546      PMCID: PMC3633153          DOI: 10.1038/nn.2953

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  50 in total

1.  Remote ischemic preconditioning prevents systemic platelet activation associated with ischemia-reperfusion injury in humans.

Authors:  C M Pedersen; N L Cruden; M R Schmidt; C Lau; H E Bøtker; R K Kharbanda; D E Newby
Journal:  J Thromb Haemost       Date:  2011-02       Impact factor: 5.824

2.  GMF-knockout mice are unable to induce brain-derived neurotrophic factor after exercise.

Authors:  Asgar Zaheer; Joel T Haas; Carlos Reyes; Satya N Mathur; Baoli Yang; Ramon Lim
Journal:  Neurochem Res       Date:  2006-05-13       Impact factor: 3.996

Review 3.  Erythropoietin in stroke: quo vadis.

Authors:  Murat Digicaylioglu
Journal:  Expert Opin Biol Ther       Date:  2010-06       Impact factor: 4.388

Review 4.  Toward a comprehensive neurobiology of IGF-I.

Authors:  Ignacio Torres-Aleman
Journal:  Dev Neurobiol       Date:  2010-04       Impact factor: 3.964

5.  Remote ischemic limb preconditioning after subarachnoid hemorrhage: a phase Ib study of safety and feasibility.

Authors:  Sebastian Koch; Michael Katsnelson; Chuanhui Dong; Miguel Perez-Pinzon
Journal:  Stroke       Date:  2011-03-17       Impact factor: 7.914

6.  Exercise modulates insulin-like growth factor 1-dependent and -independent effects on adult hippocampal neurogenesis and behaviour.

Authors:  María Llorens-Martín; Ignacio Torres-Alemán; José Luis Trejo
Journal:  Mol Cell Neurosci       Date:  2010-03-03       Impact factor: 4.314

7.  Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes.

Authors:  Gregg C Fonarow; Eric E Smith; Jeffrey L Saver; Mathew J Reeves; Deepak L Bhatt; Maria V Grau-Sepulveda; DaiWai M Olson; Adrian F Hernandez; Eric D Peterson; Lee H Schwamm
Journal:  Circulation       Date:  2011-02-10       Impact factor: 29.690

8.  Minocycline development for acute ischemic stroke.

Authors:  Susan C Fagan; Lydia E Cronic; David C Hess
Journal:  Transl Stroke Res       Date:  2011-06-01       Impact factor: 6.829

9.  The protective effects of preconditioning on cerebral endothelial cells in vitro.

Authors:  Anuska V Andjelkovic; Svetlana M Stamatovic; Richard F Keep
Journal:  J Cereb Blood Flow Metab       Date:  2003-11       Impact factor: 6.200

10.  Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke.

Authors:  Andrew N Clarkson; Ben S Huang; Sarah E Macisaac; Istvan Mody; S Thomas Carmichael
Journal:  Nature       Date:  2010-11-03       Impact factor: 49.962

View more
  159 in total

1.  Bone morphogenic protein-7 contributes to cerebral ischemic preconditioning induced-ischemic tolerance by activating p38 mitogen-activated protein kinase signaling pathway.

Authors:  Junhong Guan; Han Li; Tao Lv; Duo Chen; Ye Yuan; Shengtao Qu
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

Review 2.  Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.

Authors:  Jialing Liu; Yongting Wang; Yosuke Akamatsu; Chih Cheng Lee; R Anne Stetler; Michael T Lawton; Guo-Yuan Yang
Journal:  Prog Neurobiol       Date:  2013-11-27       Impact factor: 11.685

3.  Executive dysfunction and blockage of brain microvessels in a rat model of vascular cognitive impairment.

Authors:  Kristopher D Langdon; Chris A Cordova; Shirley Granter-Button; Jamie D Boyd; James Peeling; Timothy H Murphy; Dale Corbett
Journal:  J Cereb Blood Flow Metab       Date:  2017-10-30       Impact factor: 6.200

Review 4.  Photothrombotic Stroke as a Model of Ischemic Stroke.

Authors:  Anatoly B Uzdensky
Journal:  Transl Stroke Res       Date:  2017-11-29       Impact factor: 6.829

5.  AGO CLIP Reveals an Activated Network for Acute Regulation of Brain Glutamate Homeostasis in Ischemic Stroke.

Authors:  Mariko Kobayashi; Corinne Benakis; Corey Anderson; Michael J Moore; Carrie Poon; Ken Uekawa; Jonathan P Dyke; John J Fak; Aldo Mele; Christopher Y Park; Ping Zhou; Josef Anrather; Costantino Iadecola; Robert B Darnell
Journal:  Cell Rep       Date:  2019-07-23       Impact factor: 9.423

Review 6.  Is age a key factor contributing to the disparity between success of neuroprotective strategies in young animals and limited success in elderly stroke patients? Focus on protein homeostasis.

Authors:  Wei Yang; Wulf Paschen
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-28       Impact factor: 6.200

Review 7.  Neuroprotective action of acute estrogens: animal models of brain ischemia and clinical implications.

Authors:  Tomoko Inagaki; Anne M Etgen
Journal:  Steroids       Date:  2013-02-04       Impact factor: 2.668

8.  In vivo inhibition of the mitochondrial H+-ATP synthase in neurons promotes metabolic preconditioning.

Authors:  Laura Formentini; Marta P Pereira; Laura Sánchez-Cenizo; Fulvio Santacatterina; José J Lucas; Carmen Navarro; Alberto Martínez-Serrano; José M Cuezva
Journal:  EMBO J       Date:  2014-02-12       Impact factor: 11.598

9.  Pretreatment with Korean red ginseng or dimethyl fumarate attenuates reactive gliosis and confers sustained neuroprotection against cerebral hypoxic-ischemic damage by an Nrf2-dependent mechanism.

Authors:  Lei Liu; Mary K Vollmer; Abdullah S Ahmad; Victoria M Fernandez; Hocheol Kim; Sylvain Doré
Journal:  Free Radic Biol Med       Date:  2018-11-17       Impact factor: 7.376

Review 10.  Stroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links.

Authors:  Murali Vijayan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2016-09-06       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.